Barriers and Facilitators of Same-Day Antiretroviral Therapy Initiation Among People Newly Diagnosed with HIV in Ethiopia: Qualitative Study Using the Transtheoretical Model of Behavioral Change

References

• UNAIDS, Joint United Nations Programme on HIV/AIDS (UNAIDS); 2017. Available from: http://aidsinfo.unaids.org. Accessed 16 August 2017.
   Google Scholar
• Sidibé M, Loures L, Samb B. The UNAIDS 90–90–90 target: a clear choice for ending AIDS and for sustainable health and development. J Int AIDS Soc. 2016;19;1.
   Web of Science ®Google Scholar
• WHO. The Use of Antiretroviral Drugs for Treating and Preventing Hiv Infection Preventing Hiv Infection, 2016 Recommendations for a Public Health Approach, W.l.c.-I.-P. Data, Editor. Geneva, Switzerland: WHO; 2016.
   Google Scholar
• Ethiopia, F.M.o.H. National Guidelines for Comprehensive HIV Prevention, Care and Treatment, A.A.M.o. Health, Editor; 2017.
   Google Scholar
• FHAPCO. HIV/AIDS Strategic Plan 2015-2020 in an Investment Case Approach. FHAPCO-Ethiopia; 2015.
   Google Scholar
• Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57. doi:10.1016/S0140-6736(08)61697-9
   PubMed Web of Science ®Google Scholar
• Williams G, Lima BV, Gouws E. Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr HIV Res. 2011;9(6):367–382. doi:10.2174/157016211798038533
   PubMed Web of Science ®Google Scholar
• Cori A, Ayles H, Beyers N, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9(1):e84511. doi:10.1371/journal.pone.0084511
   PubMed Web of Science ®Google Scholar
• Hallett TB, Baeten JM, Heffron R, et al. Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study. PLoS Med. 2011;8(11):e1001123. doi:10.1371/journal.pmed.1001123
   Web of Science ®Google Scholar
• Eaton JW, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245.
   PubMed Web of Science ®Google Scholar
• Ford N, Migone C, Calmy A, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS. 2018;32(1):17. doi:10.1097/QAD.0000000000001671
   PubMed Web of Science ®Google Scholar
• Croxford S, Yin Z, Burns F, et al. Linkage to HIV care following diagnosis in the WHO European Region: A systematic review and meta-analysis, 2006-2017. PLoS One. 2018;13(2):e0192403. doi:10.1371/journal.pone.0192403
   Web of Science ®Google Scholar
• Bacon O, et al. The Rapid ART Program Initiative for HIV Diagnoses (RAPID) in San Francisco. 25th Conference on Retroviruses and Opportunistic Infections (CROI). 2018.
   Google Scholar
• Horter S, Thabede Z, Dlamini V, et al. “Life is so easy on ART, once you accept it”: acceptance, denial and linkage to HIV care in Shiselweni, Swaziland. Soc Sci Med. 2017;176:52–59. doi:10.1016/j.socscimed.2017.01.006
   PubMed Web of Science ®Google Scholar
• WHO. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV; 2015.
   Google Scholar
• Kiriazova T, Postnov O, Bingham T, et al. Patient and provider perspectives inform an intervention to improve linkage to care for HIV patients in Ukraine. BMC Health Serv Res. 2018;18(1). doi:10.1186/s12913-018-2885-4.
   Web of Science ®Google Scholar
• Horter S, Wringe A, Thabede Z, et al. “Is it making any difference?” A qualitative study examining the treatment‐taking experiences of asymptomatic people living with HIV in the context of Treat‐all in Eswatini. J Int AIDS Soc. 2019;22(1):e25220. doi:10.1002/jia2.25220
   PubMed Web of Science ®Google Scholar
• Nhassengo P, et al. Barriers and facilitators to the uptake of Test and Treat in Mozambique: A qualitative study on patient and provider perceptions. PLoS One. 2018;13(12):e0205919.
   PubMed Web of Science ®Google Scholar
• Ayieko J, Brown L, Anthierens S, et al. “Hurdles on the path to 90- 90-90and beyond”: qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018;13(8):e0202990. doi:10.1371/journal.pone.0202990
   PubMed Web of Science ®Google Scholar
• Adams AK, Zamberia AM. “I will take ARVs once my body deteriorates”: an analysis of Swazi men’s perceptions and acceptability of Test and Start. Af J AIDS Res. 2017;16:4.
   Web of Science ®Google Scholar
• Kuznetsova AV, Meylakhs AY, Amirkhanian YA, et al. Barriers and facilitators of HIV care engagement: results of a qualitative study in St. Petersburg, Russia. AIDS Behav. 2016;20(10):2433–2443. doi:10.1007/s10461-015-1282-9
   PubMed Web of Science ®Google Scholar
• Yehia BR, Stewart L, Momplaisir F, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis. 2015;15(1):246. doi:10.1186/s12879-015-0990-0
   PubMed Web of Science ®Google Scholar
• Knight R, Small W, Thomson K, et al. Implementation challenges and opportunities for HIV Treatment as Prevention (TasP) among young men in Vancouver, Canada: a qualitative study. BMC Public Health. 2016;16(1):262. doi:10.1186/s12889-016-2943-y
   Web of Science ®Google Scholar
• Boyer S, Iwuji C, Gosset A, et al. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care. 2016;28(sup3):39–51. doi:10.1080/09540121.2016.1164808
   PubMed Web of Science ®Google Scholar
• Lo Y-R, Kato M, Phanuphak N, et al. Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region. Sex Health. 2014;11(2):126–136. doi:10.1071/SH13094
   Web of Science ®Google Scholar
• MacPherson P, MacPherson EE, Mwale D, et al. Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi. J Int AIDS Soc. 2012;15(2):18020. doi:10.7448/IAS.15.2.18020
   Web of Science ®Google Scholar
• Anderson JG. Health services utilization: framework and review. Health Serv Res. 1973;8(3):184.
   Google Scholar
• Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health. 2010;31(1):399–418. doi:10.1146/annurev.publhealth.012809.103604
   PubMed Web of Science ®Google Scholar
• Kübler-Ross E, Kessler D. On Grief and Grieving: Finding the Meaning of Grief Through the Five Stages of Loss. Simon and Schuster; 2005.
   Google Scholar
• Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am j Health Promotion. 1997;12(1):38–48. doi:10.4278/0890-1171-12.1.38
   PubMed Web of Science ®Google Scholar
• Astalin PK. Qualitative research designs: A conceptual framework. Int J Social Sci Int Res. 2013;2(1):118–124.
   Google Scholar
• Ahmed I, Gugsa ST, Lemma S, et al. Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study. BMC Public Health. 2013;13(1):867. doi:10.1186/1471-2458-13-867
   Web of Science ®Google Scholar
• Clarke VBV. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:2.
   Google Scholar
• Balcha TT, Jeppsson A, Bekele A. Barriers to antiretroviral treatment in Ethiopia: a qualitative study. J Int Assoc Physicians AIDS Care. 2011;10(2):119–125. doi:10.1177/1545109710387674
   Google Scholar
• Katz IT, Essien T, Marinda ET, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS. 2011;25(17):2177. doi:10.1097/QAD.0b013e32834b6464
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Tymejczyk O, Gadisa T, et al. “Testing, Testing”: multiple HIV-Positive Tests among Patients Initiating Antiretroviral Therapy in Ethiopia. J Int Assoc Provid AIDS Care. 2017;16(6):546–554. doi:10.1177/2325957417737840
   PubMedGoogle Scholar
• Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. Aids. 2012;26(16):2059–2067. doi:10.1097/QAD.0b013e3283578b9b
   PubMed Web of Science ®Google Scholar
• Mugglin C, Estill J, Wandeler G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis. Trop Med Int Health. 2012;17(12):p. 1509–1520. doi:10.1111/j.1365-3156.2012.03089.x
   Web of Science ®Google Scholar
• Kebaabetswe P, et al. Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana. AIDS Care. 2019;1–7.
   Web of Science ®Google Scholar
• Tymejczyk O, Brazier E, Yiannoutsos C, et al. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: a metaregression analysis of programmatic data from 22 countries. PLoS Med. 2018;15(3):e1002534. doi:10.1371/journal.pmed.1002534
   Web of Science ®Google Scholar
• Layer EH, Kennedy CE, Beckham SW, et al. Multi-Level Factors Affecting Entry into and Engagement in the HIV Continuum of Care in Iringa, Tanzania. PLoS One. 2014;9(8):e104961. doi:10.1371/journal.pone.0104961
   PubMed Web of Science ®Google Scholar
• Katz IT, Dietrich J, Tshabalala G, et al. Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav. 2015;19(4):704–714. doi:10.1007/s10461-014-0920-y
   PubMed Web of Science ®Google Scholar